Editorial
Welcome to the May 2013 edition of i2P - Information to pharmacists.
Economic turbulence seems to now be arriving in Australia with forecasts of high inflation rates, which also means high interest rates following on.
This type of economic forecast also means that banks will be more fractious with their borrowers. They are already offside with pharmacy due to the high level of bankruptcies over the past two years.
There is a pent up demand for a general wage increase for pharmacists impacting at a point in this month where pharmacy gross profit generally, is in decline.
Columns
Loretta Marron BSc: Health Watch
Barry Urquhart: Marketing Focus
Harvey Mackay: Strategic Thinking
Mark Neuenschwander: I`ve been thinking about...Recent Comments
Past Editions
Volume 1 Number 1
Volume 1 Number 2
Volume 1 Number 3
Volume 1 Number 4
Volume 1 Number 5
Volume 1 Number 6
Volume 1 Number 7
Volume 2 Number 1
Volume 2 Number 2
Volume 2 Number 3
Volume 2 Number 4
Volume 2 Number 5
Volume 2 Number 6
Volume 2 Number 7
Volume 2 Number 8
Volume 2 Number 9
Volume 2 Number 10
Volume 2 Number 11
Volume 3 Number 1
Volume 3 Number 2
Volume 3 Number 3
Volume 3 Number 4
Volume 3 Number 5
Volume 3 Number 6
Volume 3 Number 7
Volume 3 Number 8
Volume 3 Number 9
Volume 3 Number 10
Volume 3 Number 11
Volume 4 Number 1
Volume 4 Number 2
Volume 4 Number 3
Volume 4 Number 4
Volume 4 Number 5
Volume 4 Number 6
Volume 4 Number 7
Volume 4 Number 8
Volume 4 Number 9
Volume 4 Number 10
Volume 4 Number 11
Volume 5 Number 1
Volume 5 Number 2
Volume 5 Number 3
Volume 5 Number 4
Health Politics
Professional Pharmacists Australia Spokesperson: Professional Pharmacists Hit Out at Abbott’s Penalty Rate Plans | open full screen
Peter Sayers: The Australian Pesticides & Veterinary Medicines Authority (APVMA) to review science on pesticides and bee healthEPublications
SHPA announces new CEO
Printer-friendly version
Send to friend
PDF version | Staff Writer |
Editing and Researching news and stories about global and local Pharmacy Issues | |
SHPA is pleased to announce the appointment of Helen Dowling as the new Chief Executive Officer of SHPA, commencing July 2012.
Helen has been the District Director of Pharmacy for the Hunter New England Local Health District since 2008, and previously was the Director of Pharmacy at the John Hunter Hospital in Newcastle, NSW.
Helen comes to SHPA with a long history of active involvement in SHPA at many levels – she is an SHPA Fellow, has served two terms on the SHPA NSW Branch committee, was a member of SHPA Federal Council from 1995-2003 where she held positions of Secretary, Vice President and President and she has chaired SHPA’s Research and Development Grants Advisory Committee. Helen’s achievements and commitment to pharmacy practice were recognised in 2005 when she was awarded the GlaxoSmithKline Medal of Merit.
Motivated by her commitment to patient safety, quality use of medicines and quality improvement in health care, Helen’s involvement in pharmacy and healthcare-related organisations is extensive. She is a member of the NSW Therapeutic Advisory Group, the Pharmacy Board of Australia Registration and Examinations Committee, Australian Pharmacy Council and she represents Allied Health Professions Australia on the Australian Council of Health Care Standards (ACHS), is a board member of ACHS and currently chairs ACHS Standing Committee. Since July 2010, she has held the position of President of the Pharmacy Council of NSW. Helen was also a member of the Independent Panel to monitor progress on NSW’s reform of the State’s public hospital system.
Helen was instrumental in the establishment of the Master of Pharmacy postgraduate degree course at the University of Newcastle in 2004; in recognition of her contribution the Faculty of Health presented Helen with an award for Outstanding Contribution to the Faculty of Health from a member of the Community. There are many other initiatives, causes and organisations to which Helen has contributed her drive and vision.
SHPA President Sue Kirsa said “SHPA is fortunate to be able to appoint a person of Helen’s calibre to the CEO position. Her experience, leadership, vision and commitment make her a perfect fit for this position and I believe that SHPA will prosper during her tenure.”
Return to home
Research Reports
Dr Andrew Byrne & Associates: Effects of sublingually given naloxone in opioid-dependent human volunteers. Preston KL, Bigelow GE, Liebson IE. Drug Alcohol De | open full screen
Staff Researcher: One step closer to a blood test for Alzheimer'sPractice Development
Fiona Sartoretto Verna AIAPP: 400 sqm in Rome: the third Lapucci Pharmacy, a pharmacy full of services | open full screen
Neil Retallick: Fair Work Ombudsman Audit – People working, people out of work
Gerald Quigley: Bright eyed & bushy tailed
Joseph Conway: What is a Pharmacist worth? 
Mark Coleman: Bigger Dispensaries are not more efficient: So why have we still got the location rules? | open full screen
Anthony Huxley & Peter Krasenstein: Why extend the house if you don’t renovate it too? | open full screen
Kay Dunkley - BPharm, Grad Dip Hosp Pharm, Grad Dip Health Admin, MPS, MSHPA: Pharmacists’ Support Service welcomes support from Meridian Lawyers | open full screen
Preventive Medicine
Dr Andrew Byrne & Associates: Effects of sublingually given naloxone in opioid-dependent human volunteers. Preston KL, Bigelow GE, Liebson IE. Drug Alcohol De | open full screen
If any difficulty is found in subscribing, please use the "Contact Us" panel found in the navigation bar with the message "subscribe" and your email address.
Post new comment